Novo Nordisk Stock News
kr268.35
1.07%
Copenhagen, Nov 06, 03:46 pm CET.
Market open.
Industry
Novo Nordisk Stock News
Novo stock popped early Wednesday on better-than-expected third-quarter sales and profit thanks to resounding beats from its GLP-1 drugs.
Today we feature a trio of interesting studies that will be presented in detail at the American Heart Association scientific sessions in Chicago this weekend.
The Danish drugmaker has had a dismal year, but its third-quarter earnings on Wednesday finally gave the market a reason to feel hopeful.
Novo Nordisk stock jumped higher on Wednesday as the Danish drugmaker lifted its guidance on strong uptake of its weight-loss drug pill that was launched this year.
The Danish drugmaker raised its guidance for the year after noting an improved outlook for its key obesity and diabetes drugs, particularly in markets outside of the U.S.
Novo Nordisk's CFO Karsten Munk Knudsen to leave company
Novo raises full-year outlook as Wegovy sales impress
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
